FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is described is a method for staining inhibition of an adhesive composition having a substrate and a layer of a pressure sensitive adhesive containing a pressure hardened adhesive and donepezil in the layer of the pressure sensitive adhesive; the layer of the pressure sensitive adhesive contains ascorbic acid, metal salt or ester of such, and metabisulphite metal salt. The method involves: the stage of preparing a mixture containing the pressure hardened adhesive, donepezil, ascorbic acid, metal salt or ester of such, and metabisulphite metal salt, and the stage of formation of the film of the pressure sensitive adhesive by applying the mixture on the substrate surface. Staining inhibition of the donepezil-containing adhesive composition enables implementing a natural colour appearance.
EFFECT: what is presented is the method for staining inhibition of donepezil-containing adhesive composition and the method for reduction of donepezil-related compounds.
4 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
STABILISED ADHESIVE COMPOSITION CONTAINING DONEPEZIL | 2007 |
|
RU2452474C2 |
STABILISED ADHESIVE COMPOSITION CONTAINING DONEPEZIL | 2007 |
|
RU2445953C2 |
METHOD FOR TIME FADING INHIBITION OF DONEPEZIL-CONTAINING ADHESIVE COMPOSITION | 2007 |
|
RU2460521C2 |
COMPOSITION FOR TRANSCUTANEOUS ABSORPTION | 2007 |
|
RU2435570C2 |
TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
DONEPEZIL-CONTAINING ADHESIVE MEDICATION AND PACKAGE FOR IT | 2009 |
|
RU2481826C2 |
TRANSDERMAL COMPOSITION CONTAINING DONEPEZIL AS ACTIVE INGREDIENT | 2015 |
|
RU2713207C2 |
TRANSCUTANEOUS ABSORPTION PREPARATION CONTAINING STABILIZED DONEPEZIL | 2019 |
|
RU2814017C2 |
PERCUTANEOUSLY ABSORBABLE PREPARATION | 2009 |
|
RU2483729C2 |
Authors
Dates
2012-09-10—Published
2007-11-30—Filed